SpyBiotech Ltd.

https://www.spybiotech.com

LinkedIn: https://www.linkedin.com/company/spybiotech

SpyBiotech is a biotechnology company with a novel vaccine platform technology to target infectious diseases, cancer and chronic diseases. The company was spun out of the University of Oxford in 2017 by Oxford Science Enterprises (OSE) and has raised $39mm to date. Based on science developed at Oxford, SpyBiotech’s novel vaccine platform is based on a proprietary protein “superglue” technology which binds antigens to vaccine delivery platforms in a way which minimizes delivery risk and enhances immunogenicity and efficacy. The technology is potentially one of the safest and most effective ways to create vaccines: cost-effective and highly scalable. This makes it ideal for use against infectious diseases in challenging environments, such as in the developing world, but also with potential application in non-infectious disease settings such as cancer. SpyBiotech has the exclusive rights from the University of Oxford to apply, commercialize and sub-license the SpyTag/SpyCatcher technology in vaccine development. *

	Start	2017-01-01 established (s-off)
	Predecessor	University of Oxford
	Industry	BIOTECH
	Industry 2	SpyCatcher/SpyTag protein »superglue« technology
	Person	Biswas, Sumi (SpyBiotech 201703– CEO + CSO + Co-Founder)

	Region	Oxford, Oxfordshire
	Country	United Kingdom (GB)
	Street	7600 Quorum Oxford Business Park North
	City	OX4 2JZ Oxford, Oxfordshire
	Tel	+44-1865-582088
		Address record changed: 2021-02-14

Basic data	Employees	n. a.

		* Document for »About Section«: SpyBiotech Ltd.. (7/12/22). "Press Release: SpyBiotech Appoints Seasoned Biotech Executive Mark Leuchtenberger as Chief Executive Officer". Oxford & Cambridge, MA.

		Record changed: 2023-07-10

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for SpyBiotech Ltd.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)